A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma
Clinical trial NCT04502862 · COMPLETED
Trial details
- NCT number
- NCT04502862
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2023-10-03
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.